Bayer to buy AskBio in deal worth up to $4B By: St. Louis Business Journal via Business Journals October 26, 2020 at 12:04 PM EDT The global pharmaceutical company is buying a North Carolina-based gene-therapy outfit in a deal that could reach as high as $4 billion. Read More >>